OncoMatch/Clinical Trials/NCT05474846
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
Is NCT05474846 recruiting? Yes, currently enrolling (May 2026). This Phase 2/3 trial studies multiple treatments including Melatonin and Melatonin for sleep.
Treatment: Melatonin · Melatonin · Methylphenidate — To learn if Cognitive Behavior Therapy (called CBT), combined with either Bright Light Therapy (called BLT), methylphenidate, and/or melatonin, can help improve sleep and other related symptoms such as fatigue, anxiety, and depression in cancer patients. This is an investigational study. In this study, BLT, Methylphenidate and Melatonin will be compared to their placebos.
Check if I qualifyEligibility summary
For patients with Cancer.
This summary was generated by AI from the trial's official eligibility criteria and may contain errors. Always confirm with the study team before contacting a site.
US trial sites
- MD Anderson Cancer Center · Houston, Texas
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify